The JSE was stronger on Wednesday alongside European markets as developments in the search for a coronavirus vaccine supported risk appetite.

News that an experimental Covid-19 vaccine trial by US biotech company Moderna has shown immune response in all 45 volunteer patients, lifted market sentiment amid concerns about the rising number of Covid-19 cases.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now